AIM Breakfasts

AIM BREAKFAST – 13th December 2016

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 988

Total number of AIM Companies trading: 960*
* As at 12 December 2016

Dish of the Day:

No AIM Joiners Today

Off the Menu:

Cancellation of  Powerflute  (POWR) following cash offer

Set Menu ISDX Growth:

Total number of ISDX Growth Market Companies (Incl Susp): 84*

Total number of ISDX Growth Market Companies trading: 81*
* As at 12 December 2016

Dish of the Day:

No ISDX Growth Market Joiners Today

Off the Menu:

No ISDX Growth Market Leavers Today

What’s Cooking in the IPO Kitchen?

Ultimate Products—The Telegraph reports Jim McCarthy, former chief of Poundland has been appointed Chairman of Ultimate Products ahead of a £100m listing in H1 2017. Ultimate Products owns the Beldray cleaning brand and the licence to sell Russell Hobbs and Salter electrical products in the UK.

ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.9m. Target date 14 Dec. Expected market cap £15m, with issue price of 167p.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

 

Breakfast Buffet

Fitbug Holdings* (FITB.L) 0.21p £2.52m

The provider of digital wellness for corporate organisations, announced a strategic partnership with Olympic gold medallist Sally Gunnell, OBE, to help promote and expand its digital wellness offering to businesses in the UK. The partnership combines Sally’s workplace wellbeing programme and Fitbug’s scalable digital platform to offer a rich corporate health and wellness proposition and to generate new growth opportunities.   Sally Gunnell commented “Working with Fitbug allows us to reach a much larger audience, and provide a more powerful programme. That way we can have a bigger impact, and create a lasting health legacy within many organisations.”

 

Mporium Group (MPM.L) 13.75p £70.7m

The “mobile native” technology firm, announced an agreement to provide its IMPACT technology product to Jellyfish, a market-leading independent digital agency. This new partnership follows the successful trial of IMPACT on the digital marketing campaign for one of Jellyfish’s largest blue-chip clients. As the world’s biggest boutique digital agency, Mporium’s partnership with Jellyfish represents a significant step in the commercialisation of IMPACT, in addition to securing the opportunity to work with Jellyfish’s global client base which includes Experian, Under Armour, Nestlé, Toyota, Fitbit and Samsung.

Tertiary Minerals (TYM.L) 1.1p £2.94m

FYSep16 results from  company building a strategic position in the fluorspar sector. Operational highlights include: Storuman Exploitation (Mine) Permit approved by the Swedish Mining Inspectorate.   Phase 4 drilling programme completed on the MB Project in Nevada.  Significant lateral and depth extensions to fluorspar mineralisation proven in the Western Area on the MB Project. Modelling, economic evaluation and metallurgical test work progressing for the MB Project. Sale of the two non-core gold assets potentially providing the Company with future cash-flow through its retained royalty interest. £474k loss. Net current assets of £461k.

European Metals Holdings (EMH.L) 37p £47.9m

EMH has announced the successful manufacture of >99.5% pure lithium carbonate using an industry proven, sodium sulphate roast-based flow-sheet from mica-concentrate from the Cinovec Project. Cinovec, which contains the largest lithium resource in Europe and one of the largest undeveloped tin resources in the world, is the Company’s 100% owned lithium and tin project located in the Czech Republic. The roasting flow-sheet reflects a simplified version of the well-proven technology that converts spodumene concentrate to lithium carbonate. Numerous lithium carbonate plants currently employ this technology internationally.

Utilitywise (UTW.L) 195p £152.62m

The independent utility cost management consultancy, has partnered with Business Stream, the UK’s third largest non-domestic water supplier. Utilitywise will offer gas and electricity procurement services and technology to Business Stream’s customer base through a joint marketing programme, initially in Scotland and additionally in England when Business Stream’s acquisition of Southern Water’s non-domestic business takes effect in April 2017. Business Stream and Southern Water currently serve approximately 90,000 and 100,000 customers respectively.

Velocys (VLS.L) 36.25p £52.16m

Strategy update from the specialist in  smaller scale gas-to-liquids. Construction of Velocys’ commercial reference plant in Oklahoma City is complete. Commissioning is ongoing. The new strategy will build on this and Velocys’ leadership position,. Pillars of the strategy include partnerships, a capital light model, a ‘one-stop-shop’ offer and leveraging its differentiated technology, engineering and operational capabilities, working seamlessly with its partners to modularise and drive down costs of the complete offer.

 

Microsaic Systems (MSYS.L) 4p £7.25m

The developer of chip-based mass spectrometry  instruments, designed to improve the efficiency of pharmaceutical  R&D has released a trading update. It is expected that EBITDA and pre-tax profit for 2016 will be broadly in line with market expectations. MSYS has reshaped its business strategy to focus on the Pharma market where clear opportunities exist for its products. Despite progress on many fronts, the business has encountered challenging trading conditions in a particular market sector, especially in H2. This will impact growth in 2017.

 

4d Pharma (DDDD.L)697.5 p £452.4m

The pharmaceutical company focusing on the development of live biotherapeutics, updated on the phase 1 clinical trial of Blautix, for the treatment of Irritable Bowel Syndrome. IBS patients receiving Blautix showed an increase in microbiome diversity and microbiome stability that was comparable to healthy controls. IBS patients receiving placebo showed a reduction in microbiome diversity and exhibited microbiome instability. This result may be indicative of a relevant therapeutic effect of Blautix & will be investigated further in phase 2 clinical studies scheduled for 2017.

 

Seeing Machines (SEE.L) 4.5p £48.4m

The technology company with a focus on operator monitoring and intervention sensing technologies and services, has conditionally raised £15 million, before expenses, through a placing and subscription at 4p. Up to a further £2m maybe raised in an overseas and Australian Offer. The Fundraising will provide growth capital to continue the ongoing commercialisation of the Company’s technology, including the FOVIO automotive business.

 

Bushveld Minerals (BMN.L) 1.58p £10.76m

The diversified mineral development company with projects in South Africa & Madagascar, has agreed terms to acquire a significant interest in the Uis Tin project through its wholly owned subsidiary, Greenhills Resources. Under the Agreement Greenhills Resources will acquire 49% interest in Dawnmin Africa Investments Ltd  which is the 85% owner of the Uis Tin Project, subject to due diligence, from a consortium of Namibian shareholders. 41m shares consideration. One of the largest undeveloped opencast hard rock tin deposits in the world and has a history of significant tin mining.

 

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX. If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.